Phoenix Holdings Discloses 60.5M Share Stake in Teva Pharma
Ticker: TEVJF · Form: SC 13G · Filed: Feb 1, 2024 · CIK: 818686
| Field | Detail |
|---|---|
| Company | Teva Pharmaceutical Industries Ltd (TEVJF) |
| Form Type | SC 13G |
| Filed Date | Feb 1, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, SC-13G
TL;DR
**Phoenix Holdings just revealed a huge stake in Teva, signaling institutional confidence.**
AI Summary
Phoenix Holdings Ltd., an Israeli financial services company, reported beneficial ownership of 60,522,178.10 ordinary shares of Teva Pharmaceutical Industries Ltd. as of December 31, 2023. This represents a significant shared voting power in Teva, indicating Phoenix Holdings has a substantial stake in the pharmaceutical giant. This matters to investors because a large institutional holding can signal confidence in the company's future, potentially influencing stock stability and future strategic decisions.
Why It Matters
This filing reveals a major institutional investor's significant stake in Teva, which can impact market perception and potentially influence corporate governance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a passive investment, not indicating any immediate negative risk to the company.
Analyst Insight
A smart investor would note this significant institutional holding as a potential indicator of long-term value, but would also research Phoenix Holdings' investment strategy and Teva's fundamentals before making any investment decisions.
Key Numbers
- 60,522,178.10 — Ordinary Shares (Number of Teva Pharmaceutical Industries Ltd. shares with shared voting power held by Phoenix Holdings Ltd. as of December 31, 2023.)
Key Players & Entities
- Phoenix Holdings Ltd. (company) — reporting person, beneficial owner of Teva shares
- Teva Pharmaceutical Industries Ltd. (company) — subject company, issuer of the securities
- 60,522,178.10 (dollar_amount) — number of shares beneficially owned with shared voting power
- December 31, 2023 (date) — date of event requiring the filing
- Israel (company) — place of organization for Phoenix Holdings Ltd.
Forward-Looking Statements
- Phoenix Holdings Ltd. will maintain its significant stake in Teva Pharmaceutical Industries Ltd. for the foreseeable future. (Phoenix Holdings Ltd.) — medium confidence, target: December 31, 2024
FAQ
Who is the reporting person in this SC 13G filing?
The reporting person is Phoenix Holdings Ltd., as stated in the 'NAME OF REPORTING PERSONS' section of the filing.
What is the name of the issuer whose securities are being reported?
The issuer is Teva Pharmaceutical Industries Ltd., as indicated under 'Name of Issuer' on the Schedule 13G.
How many shares does Phoenix Holdings Ltd. have shared voting power over?
Phoenix Holdings Ltd. has shared voting power over 60,522,178.10 ordinary shares, as detailed in 'NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH SHARED VOTING POWER' on page 2 of 8.
What was the date of the event which required this filing?
The date of the event which required this filing was December 31, 2023, as specified on the Schedule 13G cover page.
What is the CUSIP number for the class of securities reported?
The CUSIP number for the Ordinary Shares, par value NIS 0.10 per share, is M8769Q102, as listed on the Schedule 13G cover page.
Filing Stats: 1,237 words · 5 min read · ~4 pages · Grade level 11 · Accepted 2024-02-01 08:03:56
Filing Documents
- zk2430871.htm (SC 13G) — 65KB
- exhibit_1.htm (EX-99) — 11KB
- 0001178913-24-000343.txt ( ) — 78KB
(a)
Item 1. (a) Name of Issuer : Teva Pharmaceutical Industries Ltd. (b) Address of Issuer's Principal Executive Offices : 124 Dvora HaNevi'a Street, Tel Aviv, TA 6944020, Israel
(a)
Item 2. (a) Name of Person Filing : The Phoenix Holdings Ltd. The securities reported herein are beneficially owned by various direct or indirect, majority or wholly-owned subsidiaries of the Phoenix Holdings Ltd. (the "Subsidiaries"). The Subsidiaries manage their own funds and/or the funds of others, including for holders of exchange-traded notes or various insurance policies, members of pension or provident funds, unit holders of mutual funds, and portfolio management clients. Each of the Subsidiaries operates under independent management and makes its own independent voting and investment decisions. (b) Address of Principal Business Office : The address of the Phoenix Holdings Ltd. is Derech Hashalom 53, Givataim, 53454, Israel. (c) Citizenship : The Phoenix Holdings Ltd. - Israel (d) Title of Class of Securities : Ordinary Shares, par value NIS 0.10 per share (e) CUSIP Number : M8769Q102 Item 3 . Not applicable. Item 4 . (a) Amount beneficially owned : See row 9 of cover page of each reporting person. Each of the Subsidiaries operates under independent management and makes its own independent voting and investment decisions. Neither the filing of this Schedule 13G nor any of its contents shall be deemed to constitute an admission by either the Filing Persons or Subsidiaries that a group exists for purposes of Section 13(d) of the Securities Exchange Act of 1934 or for any other purpose, and each reporting person disclaims the existence of any such group. In addition, each of the Filing Persons and Subsidiaries disclaims any beneficial ownership of the securities covered by this report in excess of their actual pecuniary interest therein. This